Cancer Screening

Dr Hayes, Immediate Past President of ASCO and Professor of Breast Cancer Research at the University of Michigan Comprehensive Cancer Center, explains how biomarkers offer more precise treatment opportunities for patients with breast cancer.

CancerSEEK is a noninvasive blood test that may help detect cancer in early stages, when treatment has the highest chance for success.

Liquid biopsy is a noninvasive blood test that can help identify cancerous cells or biomarkers, such as gene mutations that may respond to targeted therapies.

Biomarkers are biologic markers that indicate changes in our genes and may increase the risk of cancer.

This first-ever direct-to-consumer genetic test can provide information on potential risks to individuals who may not have access to genetic screening, but the information may be misleading without feedback from experts.

This week is Cancer Screen Week—a nationwide public health initiative to increase awareness of the benefits of early cancer detection.

You know Ben Stiller as the comedic actor who made you laugh in “There’s Something About Mary,” “Zoolander,” and “Meet the Parents,” but this legend of the silver screen credits a PSA screening for saving his life.

Low-dose CT screening is the only screening method recommended by the US Preventive Services Task Force for lung cancer, yet only 3.9% of eligible people are actually screened.